Monday, March 21 Replay

09.00 | 12.00 SCREENING and perspectives:

Personalized screening programs in 2022?

9.00 I 9.15
Prof. Naglaa ABDEL RAZEK
CONTINUE READING

IA and breast screening: New tools and paradigms.

9.15 I 9.30
Prof. Isabelle THOMASSIN NAGGARA
AVAILABLE
CONTINUE READING

The added value of shear-wave elastography in US imaging.

9.30 I 9.45
Dr. Foucauld CHAMMING'S
AVAILABLE
CONTINUE READING

Overview of high-risk patient screening.

9.45 I 10.00
Dr. Dana HADDAD
AVAILABLE  
CONTINUE READING

Risk assessment, personalized screening, and Artificial Intelligence Chairpersons: Prof. Mustapha BOUBRIT (DZ), Prof. Patrice TAOUREL (FR), Dr. Kinda DAIDOUAIRI (UAE), Prof. Naglaa ABDEL RAZEK (EG)

10.45 | 12.15 SCREENING and the future: New tools and economics

Chairpersons: Dr. Dana HADDAD (UAE), Prof. Isabelle THOMASSIN NAGGARA (FR), Prof. Asma ZIDI (TN), Prof. Marc SPIELMANN (FR)

14:00 | 15:30 IDC and PRE‐MALIGNANT LESIONS

Second-look US identification prior to guided biopsy.

14.00 | 14.15
Dr. Luc ROTENBERG
AVAILABLE
CONTINUE READING

VAB and VAE: To sample or to excise?

14.15 | 14.30
Dr. Gregory LENCZNER
AVAILABLE
CONTINUE READING

Premalignant lesions: When to avoid open surgery?

14.30 | 14.45
Dr. Foucauld CHAMMING’S
AVAILABLE
CONTINUE READING

Wireless localization of non-palpable breast tumors.

14.45 | 15.00
Dr. Paul SAYAD
AVAILABLE
CONTINUE READING

Radiotherapy: Indications and progress in IDC.

15.00 | 15.15
Prof. Yazid BELKACEMI
AVAILABLE
CONTINUE READING

Chairpersons: Prof. Wahib BOUBNIDER (DZ), Dr. Luc ROTENBERG (FR), Prof. Yazid BELKACEMI (FR), Dr Paul SAYAD (UAE)

16:00 | 17:30 UPDATED STANDARDS IN HR+ NON‐METASTATIC DISEASE

Preoperative assessment: How far to go in imaging?

16.00 | 16.15
Prof. Dalila AHNOU
AVAILABLE
CONTINUE READING

Biological and anatomo-pathological characteristics.

16.15 | 16.30
Prof. Frederique PENAULT LORCA
AVAILABLE
CONTINUE READING

Robotic surgery: Indications and management.

16.30 | 16.45
Dr. Benjamin SARFATI
AVAILABLE
CONTINUE READING

Pre pectoral breast reconstruction: new way of thinking.

16.45 | 17.00
Dr. Benjamin SARFATI
AVAILABLE
CONTINUE READING

HR+/HER2- non-metastatic disease adjuvant management in 2022.

17.00 | 17.15
Prof. Marc SPIELMANN, Prof. Joseph GLIGOROV
AVAILABLE
CONTINUE READING

Chairpersons: Dr Eric Charles ANTOINE (FR), Prof. Dalila AHNOU (DZ), Dr. Jean GUIGUI (FR), Prof. Frederique PENAULT LORCA (FR)

17.30 I 18.30 LOW and MIDDLE INCOME COUNTRIES (LMICs): Minimal requirements
and challenges for Breast Cancer Care in 2022

AROME (Association of Radiotherapy and Oncolgy of the Mediterranean Area) – BCU Join Session

Tuesday March 22 Replay

9.00 | 10.30 UPDATED STANDARDS IN TRIPLE NEGATIVE NON‐METASTATIC DISEASE

Chairpersons: Prof. Hamida GENDOUZ (DZ), Dr. Eric Charles ANTOINE (FR), Dr. Eric ZERBIB (FR), Prof. Corinne BALLEYGUIER (FR)

11.00 I 12.15 UPDATED STANDARDS IN HER2+ NON‐METASTATIC DISEASE

Chairpersons: Prof. Joseph GLIGOROV (FR), Dr. Albert COHEN (FR), Dr. Didier BOUGEOIS (FR), Dr. Kadria SAYED (UAE)

14.30 | 15.45 BREAST CANCER IN EDERLY WOMEN

Chairpersons: Dr. Gregory LENCZNER (FR), Prof. Marc SPIELMANN (FR), Prof. Asma ZIDI (TN)

16.15 | 17.00 BREAST CANCER IN EDERLY WOMEN

Radiotherapy options for elderly women.

16.15 I 16.30
Prof. Yazid BELKACEMI
AVAILABLE
CONTINUE READING

Therapeutic options and adjuvant therapy.

16.30 I 16.45
Dr. Maroun KHOURY
AVAILABLE
CONTINUE READING

Chairpersons: Dr. Maroun KHOURY (UAE), Prof. Yazid BELKACEMI (FR), Prof. Wahid BOUBNIDER (DZ)

To view this content, you have to be logged in or become a member.

Existing Users Log In